IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).
IMIDomics's investors include Bristol-Myers Squibb, Union Chimique Belge, Evotec, Tao Capital Partners, DNS Capital.
IMIDomics is headquartered in Barcelona, Spain.
IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).
IMIDomics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IMIDomics — Funding & Investors." VCBacked, March 4, 2024, https://www.vcbacked.co/company/imidomics. Accessed August 15, 2026.
VCBacked. (2024). IMIDomics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/imidomics
{{cite web |title=IMIDomics — Funding & Investors |url=https://www.vcbacked.co/company/imidomics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated